{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+as+both+treatments", "query": { "intervention": "Placebo as both treatments" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 232, "total_pages": 24, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+as+both+treatments&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-05T18:42:05.583Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01706328", "title": "A Study to Assess the Efficacy of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25 mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50 mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "FF/VI 100/25 Inhalation Powder NDPI", "type": "DRUG" }, { "name": "Fluticasone Propionate/Salmeterol 250/50 Inhalation Powder ACCUHALER/DISKUS", "type": "DRUG" }, { "name": "Placebo Inhalation Powder NDPI", "type": "DRUG" }, { "name": "Placebo Inhalation Powder ACCUHALER/DISKUS", "type": "DRUG" }, { "name": "Salbutamol as needed", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 828, "start_date": "2012-10-15", "completion_date": "2013-06-17", "has_results": true, "last_update_posted_date": "2018-05-02", "last_synced_at": "2026-10-05T18:42:05.583Z", "location_count": 16, "location_summary": "Clearwater, Florida • DeLand, Florida • Coeur d'Alene, Idaho + 13 more", "locations": [ { "city": "Clearwater", "state": "Florida" }, { "city": "DeLand", "state": "Florida" }, { "city": "Coeur d'Alene", "state": "Idaho" }, { "city": "Normal", "state": "Illinois" }, { "city": "Woodbury", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01706328" }, { "nct_id": "NCT04335461", "title": "Postop Pain Control in Hip Fracture Surgery: Fascia Iliaca Compartment Block Versus Fracture Block", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Hip Fractures", "Analgesia", "Opioid Use", "Pain, Postoperative" ], "interventions": [ { "name": "Cephalomedullary nailing of extracapsular hip fracture", "type": "PROCEDURE" }, { "name": "cephalomedullary nail", "type": "DEVICE" }, { "name": "Regional Anesthetics", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DEVICE", "DRUG" ], "sponsor": "Montefiore Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 0, "start_date": "2021-08-05", "completion_date": "2023-03-17", "has_results": false, "last_update_posted_date": "2023-07-13", "last_synced_at": "2026-10-05T18:42:05.583Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04335461" }, { "nct_id": "NCT00759941", "title": "A Comparison of Azopt Versus Placebo Added to Xalatan in Patients With Elevated Intraocular Pressure (IOP) on a Prostaglandin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Glaucoma" ], "interventions": [ { "name": "Brinzolamide 1% ophthalmic solution (Azopt)", "type": "DRUG" }, { "name": "Placebo eye drops", "type": "DRUG" }, { "name": "Latanoprost 0.005% ophthalmic solution (Xalatan)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alcon Research", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": null, "sex": "ALL", "summary": "35 Years and older" }, "enrollment_count": 86, "start_date": "2007-10", "completion_date": "2009-07", "has_results": true, "last_update_posted_date": "2014-01-13", "last_synced_at": "2026-10-05T18:42:05.583Z", "location_count": 1, "location_summary": "Fort Worth, Texas", "locations": [ { "city": "Fort Worth", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00759941" }, { "nct_id": "NCT06433635", "title": "Sequential Multiple Assignment Randomized Trial for Bipolar Depression", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Bipolar I Disorder", "Depression" ], "interventions": [ { "name": "Cariprazine", "type": "DRUG" }, { "name": "Aripiprazole/Escitalopram combination", "type": "DRUG" }, { "name": "Quetiapine", "type": "DRUG" }, { "name": "Lurasidone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 2726, "start_date": "2024-10-01", "completion_date": "2030-02-28", "has_results": false, "last_update_posted_date": "2025-12-16", "last_synced_at": "2026-10-05T18:42:05.583Z", "location_count": 17, "location_summary": "Birmingham, Alabama • Bloomington, Indiana • Baltimore, Maryland + 13 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Bloomington", "state": "Indiana" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Belmont", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06433635" }, { "nct_id": "NCT03055338", "title": "An Active-Controlled Early Phase Study of Elpipodect (MK-8189) in Adults With Schizophrenia (MK-8189-005)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia, Acute Episode" ], "interventions": [ { "name": "Elpipodect", "type": "DRUG" }, { "name": "Risperidone", "type": "DRUG" }, { "name": "Placebo matching MK-8189", "type": "DRUG" }, { "name": "Placebo matching risperidone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 224, "start_date": "2017-03-08", "completion_date": "2018-01-09", "has_results": true, "last_update_posted_date": "2026-04-29", "last_synced_at": "2026-10-05T18:42:05.583Z", "location_count": 28, "location_summary": "Little Rock, Arkansas • Rogers, Arkansas • Bellflower, California + 23 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Rogers", "state": "Arkansas" }, { "city": "Bellflower", "state": "California" }, { "city": "Cerritos", "state": "California" }, { "city": "Garden Grove", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03055338" }, { "nct_id": "NCT00890526", "title": "Intervention for Reduced Sound Tolerance", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hyperacusis" ], "interventions": [ { "name": "Sound Therapy (Tinnitus Retraining Therapy)", "type": "OTHER" }, { "name": "Counseling (Tinnitus Retraining Therapy)", "type": "OTHER" }, { "name": "No Counseling", "type": "OTHER" }, { "name": "Placebo Sound Therapy", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Alabama, Tuscaloosa", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 36, "start_date": "2002-07", "completion_date": "2010-09", "has_results": false, "last_update_posted_date": "2012-06-21", "last_synced_at": "2026-10-05T18:42:05.583Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00890526" }, { "nct_id": "NCT06723743", "title": "Transcutaneous Vagus Nerve Stimulation for Attention and Memory", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Traumatic Brain Injury (TBI) Patients" ], "interventions": [ { "name": "Transcutaneous vagus nerve stimulation for attention in veterans with TBI", "type": "OTHER" }, { "name": "Soterix Medical Vagus Nerve Stimulation mini-CT", "type": "DEVICE" } ], "intervention_types": [ "OTHER", "DEVICE" ], "sponsor": "Baylor College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "25 Years to 64 Years" }, "enrollment_count": 30, "start_date": "2026-12", "completion_date": "2027-08", "has_results": false, "last_update_posted_date": "2026-10-05", "last_synced_at": "2026-10-05T18:42:05.583Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06723743" }, { "nct_id": "NCT01087736", "title": "Topiramate Treatment of Alcohol Use Disorders in Veterans With Post Traumatic Stress Disorder (PTSD): A Pilot Controlled Trial of Augmentation Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "PTSD", "Alcohol Abuse", "Alcoholism" ], "interventions": [ { "name": "Topiramate", "type": "DRUG" }, { "name": "Placebo administration", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 30, "start_date": "2010-04", "completion_date": "2013-12", "has_results": true, "last_update_posted_date": "2014-06-03", "last_synced_at": "2026-10-05T18:42:05.583Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01087736" }, { "nct_id": "NCT05407207", "title": "Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes Mellitus", "Hemodialysis Complication", "Cardiovascular Complication", "Quality of Life" ], "interventions": [ { "name": "Tennant Biomodulator ®", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Hamad Medical Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 100, "start_date": "2018-06-01", "completion_date": "2022-11-11", "has_results": false, "last_update_posted_date": "2022-06-07", "last_synced_at": "2026-10-05T18:42:05.583Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05407207" }, { "nct_id": "NCT01087788", "title": "Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Arthritis, Psoriatic" ], "interventions": [ { "name": "CZP 200 mg Q2W", "type": "BIOLOGICAL" }, { "name": "CZP 400 mg Q4W", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "UCB BIOSCIENCES GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 409, "start_date": "2010-03", "completion_date": "2015-08", "has_results": true, "last_update_posted_date": "2018-08-01", "last_synced_at": "2026-10-05T18:42:05.583Z", "location_count": 27, "location_summary": "Birmingham, Alabama • Tuscaloosa, Alabama • Peoria, Arizona + 24 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Palm Desert", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01087788" } ] }